CRYM

CRYM (Crystallin Mu) is a multifunctional protein involved in thyroid hormone regulation, neurotransmission, and metabolic pathways, playing a key role in ketimine reduction and intracellular triiodothyronine (T3) availability. 

Its dysregulation has been implicated in neurological disorders, hearing loss, prostate cancer progression, and metabolic dysfunction, making it a critical target for genetic testing and clinical research.

What is CRYM?

The CRYM (Crystallin Mu) gene encodes μ-crystallin, a multifunctional protein involved in thyroid hormone regulation, neurotransmission, and metabolic pathways. 

It functions as a ketimine reductase, catalyzing the reduction of cyclic ketimines such as cystathionine ketimine (CysK) and lanthionine ketimine (LK), which are implicated in oxidative stress and neurotransmitter metabolism. 

Ketimines are naturally occurring sulfur-containing compounds with a cyclic structure, including lanthionine ketimine (LK) and cystathionine ketimine (CK). These molecules are byproducts of the body's sulfur metabolism and have been found to support brain health by reducing oxidative stress, protecting nerve cells, and promoting the body's ability to clear damaged proteins. 

CRYM also binds NADPH and acts as a reversible inhibitor of triiodothyronine (T3), regulating intracellular thyroid hormone availability and influencing gene expression, metabolism, and neurodevelopment.

CRYM in the Brain and Nervous System

CRYM is highly expressed in the striatum, and may also be found in the cortex, hippocampus, and amygdala, where it plays a critical role in neuromodulation and synaptic regulation. 

CRYM modulates GABAergic signaling in the striatal astrocytes, helping maintain the balance between excitatory and inhibitory neurotransmission. 

Research linked CRYM dysfunction to neuropsychiatric disorders such as Huntington’s disease (HD), schizophrenia, and obsessive-compulsive disorder (OCD). Loss of CRYM in striatal astrocytes disrupts orbitofrontal cortex-striatum connectivity, leading to perseverative behaviors—a hallmark of psychiatric and neurodegenerative conditions.

Clinical Implications of CRYM Deficiency

CRYM deficiency may have the following clinical implications:

Neurological and Psychiatric Disorders

CRYM deficiency is associated with Huntington’s disease, obsessive-compulsive behaviors, and altered neurotransmission. Its overexpression has shown neuroprotective effects by mitigating mutant huntingtin (mHtt) toxicity.

Hearing Loss

Mutations in CRYM cause autosomal dominant non-syndromic deafness (DFNA40), highlighting its role in auditory function and sensorineural processing.

Thyroid Hormone and Metabolism

By regulating T3 availability, CRYM may influence metabolic pathways, affecting muscle function, malignancies, and endocrine balance.

Substance Use Disorders

CRYM expression in the medial amygdala appears to modulate sex-specific behavioral responses to social experience and drug reward, implicating it in addiction susceptibility.

Who Should Get CRYM Tested?

Given its connection to thyroid function, cancer risk, and neurological health, CRYM testing may be beneficial for:

Individuals at Risk for Prostate Cancer 

CRYM plays a complex role in prostate cancer by blocking thyroid hormone (T3) and androgen signaling, both of which drive tumor growth. Low CRYM levels are linked to worse prognosis and faster disease progression, suggesting it may act as a protective factor against aggressive prostate cancer.

Patients with Thyroid Dysfunction 

Since CRYM binds to T3, abnormal levels may indicate altered thyroid hormone metabolism, which could contribute to symptoms of thyroid imbalance.

People with Neurological or Muscular Disorders

CRYM has been linked to neurodegenerative diseases like Huntington’s disease and may play a role in muscle function and metabolism.

Test Procedure and Interpretation

Testing for CRYM is often performed as a genetic test to look for mutations in the gene that would alter functional protein availability. The following section outlines the testing procedures and interpretation.

Testing Procedure and Preparation

Genetic testing involves blood, saliva, or cheek swab samples, although specialized laboratories may recommend different sample types. 

A cheek swab or saliva sample is easily obtained from the comfort of home, while blood samples typically require a blood draw.

Normal Reference Ranges

Normal reference ranges for CRYM genetic testing are considered to be without mutations that can alter the activity of the CRYM proteins.

Clinical Implications of Positive CRYM Mutations

The clinical implications of a positive CRYM mutation test result will vary by individual, although CRYM mutations in symptomatic patients may signal a need for further assessment and possibly treatment, especially in the setting of various symptoms.

Patients or practitioners with questions about the clinical implications of CRYM mutations should seek further assessment with a genetic counselor or expert. 

Order Genetic Testing

Click here to compare genetic test panels and order genetic testing for health-related SNPs.